Global Minimally Invasive Thoracic Surgery Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Lobectomy, Wedge Resection, Pneumonectomy, and Others.By Devices;
Rigid Endoscopes and Flexible Endoscopes.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Minimally Invasive Thoracic Surgery Market (USD Million), 2021 - 2031
In the year 2024, the Global Minimally Invasive Thoracic Surgery Market was valued at USD 3,939.53 million. The size of this market is expected to increase to USD 7,064.01 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.
The global minimally invasive thoracic surgery market represents a transformative approach to treating a spectrum of thoracic conditions with enhanced precision, reduced trauma, and quicker recovery times. Thoracic surgery encompasses procedures involving the chest cavity, lungs, esophagus, and other thoracic organs, including lung resections, mediastinal tumor excisions, esophagectomies, and thoracic sympathectomies. Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS), have revolutionized the field by enabling surgeons to perform complex thoracic procedures through small incisions, aided by advanced imaging and robotic technology.
The global minimally invasive thoracic surgery market is the increasing adoption of minimally invasive techniques over traditional open surgeries due to their numerous advantages. Minimally invasive thoracic surgeries offer patients reduced postoperative pain, shorter hospital stays, faster recovery times, and improved cosmetic outcomes compared to conventional open approaches. These benefits contribute to enhanced patient satisfaction, reduced healthcare costs, and improved overall quality of care. Moreover, minimally invasive techniques are associated with lower rates of complications such as wound infections, blood loss, and respiratory complications, making them particularly attractive options for high-risk patients and those with comorbidities.
Technological advancements and innovations in minimally invasive thoracic surgery continue to drive market growth and expand the scope of procedures that can be performed using minimally invasive techniques. The integration of advanced imaging modalities, such as high-definition cameras and intraoperative navigation systems, enables surgeons to visualize and access thoracic structures with greater clarity and precision. Robotic-assisted thoracic surgery systems offer surgeons enhanced dexterity, ergonomics, and control, allowing for more intricate and complex procedures with improved outcomes. As a result, the global minimally invasive thoracic surgery market is poised for continued growth, driven by advancements in technology, increasing surgeon expertise, and expanding indications for minimally invasive approaches in thoracic surgery.
Global Minimally Invasive Thoracic Surgery Recent Development & Market
-
In November 2023, Johnson & Johnson MedTech's MONARCH Platform and MONARCH Bronchoscope received regulatory clearance in China, marking a significant advancement in minimally invasive surgical technology. This approval established the MONARCH system as the first robotic-assisted platform for peripheral lung procedures in the Chinese market.
-
In October 2023, The FDA approved Medtronic plc's Aurora EV-ICD systems for treating dangerously fast heart rhythms that could lead to sudden cardiac arrest (SCA). These systems were similar in size to traditional ICDs but were implanted below the left armpit, with the lead placed under the breastbone using a minimally invasive approach.
Segment Analysis
The global minimally invasive thoracic surgery market is characterized by a nuanced segmentation that reflects the diverse range of thoracic conditions treated and the variety of procedures performed using minimally invasive techniques. One primary segmentation criterion is based on the type of procedure, which includes lung resections, mediastinal surgeries, esophagectomies, and other thoracic interventions. Lung resections, including lobectomies, segmentectomies, and wedge resections, represent a significant segment of the market, driven by the increasing prevalence of lung cancer and the adoption of minimally invasive approaches for lung cancer treatment. Minimally invasive techniques such as VATS and RATS enable surgeons to perform lung resections with smaller incisions, reduced morbidity, and faster recovery times compared to traditional open surgeries, driving demand for minimally invasive thoracic surgical instruments and equipment.
The segmentation of the minimally invasive thoracic surgery market extends to the type of thoracic conditions treated and the patient population served. This includes a wide range of thoracic diseases and disorders, such as lung cancer, esophageal cancer, thymomas, mediastinal tumors, and benign thoracic conditions. Minimally invasive techniques are utilized for both diagnostic and therapeutic purposes, including biopsy, staging, tumor resection, lymph node dissection, and palliative interventions. The market caters to patients across different age groups, disease stages, and treatment preferences, offering minimally invasive thoracic surgical solutions that prioritize patient safety, comfort, and clinical outcomes. Overall, the segmentation of the global minimally invasive thoracic surgery market enables stakeholders to tailor products, services, and strategies to meet the diverse needs of surgeons, patients, and healthcare facilities across various thoracic specialties and procedures.
Global Minimally Invasive Thoracic Surgery Segment Analysis
In this report, the Global Minimally Invasive Thoracic Surgery Market has been segmented by Type, Devices, and Geography.
Global Minimally Invasive Thoracic Surgery Market, Segmentation by Type
The Global Minimally Invasive Thoracic Surgery Market has been segmented by Type into Lobectomy, Wedge Resection, Pneumonectomy, and Others.
Lobectomy which involves the surgical removal of one or more lobes of the lung. Lobectomy is commonly performed to treat lung cancer, lung nodules, and other thoracic malignancies, and it represents a cornerstone of minimally invasive thoracic surgery. Minimally invasive techniques such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS) enable surgeons to perform lobectomy through small incisions, resulting in reduced postoperative pain, shorter hospital stays, and faster recovery times compared to traditional open approaches. These advancements have led to increased adoption of minimally invasive lobectomy procedures and contributed to the growth of the minimally invasive thoracic surgery market.
Wedge resection which involves the surgical removal of a small, wedge-shaped portion of lung tissue. Wedge resection is performed to diagnose and treat lung nodules, localized lung tumors, and other focal lesions within the lung. Minimally invasive wedge resection procedures utilize VATS or RATS techniques to access and excise the targeted lung tissue through small incisions, minimizing trauma to surrounding structures and preserving lung function. As a result, minimally invasive wedge resection has become a preferred option for patients with early-stage lung cancer and other localized lung lesions, driving demand for minimally invasive thoracic surgical instruments and equipment.
Pneumonectomy represents another type of thoracic surgery segment within the minimally invasive market, involving the complete surgical removal of one lung. Pneumonectomy is indicated for patients with extensive lung tumors, advanced lung disease, or severe trauma affecting one lung. While minimally invasive techniques have been successfully applied to select cases of pneumonectomy using VATS or RATS, this procedure remains more commonly performed via traditional open approaches due to its complexity and the need for extensive lung resection. However, ongoing advancements in robotic technology and surgical techniques may expand the application of minimally invasive pneumonectomy in the future, potentially impacting the growth trajectory of the minimally invasive thoracic surgery market.
Global Minimally Invasive Thoracic Surgery Market, Segmentation by Device
The Global Minimally Invasive Thoracic Surgery Market has been segmented by Device into Rigid Endoscopes and Flexible Endoscopes.
Rigid endoscopes represent a traditional and widely used tool in minimally invasive thoracic surgery, offering surgeons a straight, rigid view of the surgical site through a cylindrical tube with an attached camera and light source. These endoscopes are typically utilized for procedures that require a direct line of sight, such as diagnostic thoracoscopy, lung biopsy, and pleural effusion drainage. Rigid endoscopes enable surgeons to visualize and access thoracic structures with clarity and precision, facilitating accurate diagnosis and targeted interventions.
Flexible endoscopes on the other hand, offer greater maneuverability and versatility in minimally invasive thoracic surgery, featuring a flexible shaft that can navigate through tortuous anatomical pathways and around corners within the thoracic cavity. These endoscopes are equipped with advanced imaging capabilities, including high-definition cameras and flexible tip articulation, enabling surgeons to visualize and access hard-to-reach areas of the thorax with ease. Flexible endoscopes are particularly well-suited for procedures such as esophageal stent placement, mediastinal tumor resection, and thoracic duct ligation, where flexibility and adaptability are essential for navigating complex anatomical structures and performing delicate maneuvers.
The choice between rigid and flexible endoscopes in minimally invasive thoracic surgery depends on various factors, including the type of procedure, the anatomical site involved, and surgeon preference. While rigid endoscopes offer superior image quality and stability, flexible endoscopes provide greater maneuverability and access to challenging anatomical regions. Surgeons may select the appropriate endoscope based on the specific requirements of the procedure and the patient's anatomy, aiming to optimize visualization, access, and surgical outcomes.
Global Minimally Invasive Thoracic Surgery Market, Segmentation by Geography
In this report, the Global Minimally Invasive Thoracic Surgery Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Minimally Invasive Thoracic Surgery Market Share (%), by Geographical Region, 2024
North America emerged as a dominant market for minimally invasive thoracic surgery, capturing a significant share of global sales. The region benefits from advanced healthcare systems, high adoption rates of minimally invasive techniques, and substantial investments in surgical technology and innovation. Moreover, collaborations between academic institutions, healthcare providers, and industry stakeholders drive advancements in minimally invasive thoracic surgery, contributing to market growth in North America.
Europe represented another significant market for minimally invasive thoracic surgery, encompassing countries such as Germany, the United Kingdom, and France. The region boasts a well-established healthcare infrastructure, sophisticated surgical practices, and a growing emphasis on minimally invasive approaches to thoracic surgery. European countries invest in research and development, training programs, and quality improvement initiatives to enhance the adoption of minimally invasive techniques and improve patient outcomes. Additionally, regulatory frameworks and reimbursement policies support the use of minimally invasive thoracic surgery, fostering market expansion in Europe.
The Asia Pacific region emerged as a rapidly growing market for minimally invasive thoracic surgery, driven by rising healthcare expenditure, expanding access to healthcare services, and increasing prevalence of thoracic diseases in countries such as China, India, and Japan. The region's growing demand for advanced surgical interventions, coupled with investments in medical technology and infrastructure, fuels market growth in Asia Pacific. Moreover, partnerships between international manufacturers and local distributors facilitate market penetration and product accessibility, catering to the needs of surgeons and patients across diverse healthcare settings.
Latin America and the Middle East & Africa regions also contribute to the global minimally invasive thoracic surgery market, albeit to a lesser extent compared to North America, Europe, and Asia Pacific. These regions witness steady growth driven by improving healthcare infrastructure, rising investments in medical technology, and increasing adoption of minimally invasive surgical techniques. Moreover, efforts to address unmet medical needs, enhance surgical capabilities, and improve patient outcomes stimulate market growth in Latin America and the Middle East & Africa, contributing to the overall expansion of the global minimally invasive thoracic surgery market.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Minimally Invasive Thoracic Surgery Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological Advancements
- Increasing Prevalence of Thoracic Diseases
- Growing Aging Population
-
Demand for Minimally Invasive Procedures - The demand for minimally invasive procedures has been steadily increasing across various medical specialties due to several factors driving patient and physician preferences. Minimally invasive procedures offer several advantages over traditional open surgeries, including smaller incisions, reduced trauma to surrounding tissues, shorter hospital stays, faster recovery times, and lower rates of complications. These benefits contribute to improved patient outcomes and satisfaction, leading to a growing preference for minimally invasive approaches among patients seeking treatment for a wide range of medical conditions.
Advancements in medical technology have played a significant role in driving the demand for minimally invasive procedures. Innovations such as laparoscopic and robotic-assisted surgical techniques have expanded the scope of minimally invasive surgery, allowing surgeons to perform increasingly complex procedures with greater precision and control. Additionally, advancements in imaging modalities, such as ultrasound, CT scans, and MRI, enable surgeons to visualize internal structures more clearly, enhancing the accuracy and safety of minimally invasive procedures.
The demand for minimally invasive procedures is expected to continue to grow as patients, physicians, and healthcare systems recognize the benefits of these approaches in terms of improved outcomes, enhanced patient experience, and cost savings. Continued investment in research, technology development, and physician training will further drive innovation and expand the availability of minimally invasive options across a wide range of medical specialties.
Restraints
- High Initial Investment Costs
- Technical Complexity and Training Requirements
- Limited Accessibility in Developing Regions
-
Risk of Complications and Adverse Events - The risk of complications and adverse events is an inherent concern in any medical procedure, including minimally invasive surgeries (MIS). While MIS techniques offer several advantages over traditional open surgeries, such as smaller incisions and reduced trauma to surrounding tissues, they are not without risks. Complications can arise during any phase of the surgical process, from patient selection and preoperative planning to intraoperative execution and postoperative care.
Potential complications of MIS include bleeding, organ injury, nerve damage, and adverse reactions to anesthesia or medications. These risks are inherent to any surgical procedure and can vary depending on factors such as the patient's underlying health conditions, the complexity of the surgery, and the surgeon's skill and experience. Surgeons must thoroughly assess each patient's individual risk profile and discuss the potential benefits and risks of MIS versus traditional open surgery to make informed treatment decisions.
The overall incidence of complications and adverse events associated with MIS tends to be lower compared to open surgeries. However, it is essential for healthcare providers to remain vigilant and proactive in identifying and managing potential complications to ensure patient safety and optimize surgical outcomes. This may involve regular monitoring of patients during the perioperative period, early recognition and intervention for any signs of complications, and ongoing communication and collaboration among members of the surgical team.
Opportunities
- Expansion of Minimally Invasive Techniques
- Advancements in Robotic-Assisted Surgery
- Emerging Markets Penetration
-
Integration of Imaging Technologies - The integration of imaging technologies plays a pivotal role in advancing minimally invasive surgical (MIS) procedures by providing surgeons with real-time visualization and guidance during operations. Imaging modalities such as ultrasound, fluoroscopy, computed tomography (CT), magnetic resonance imaging (MRI), and intraoperative endoscopy enable surgeons to visualize internal anatomical structures with high resolution and accuracy. By integrating these imaging technologies into MIS platforms, surgeons can enhance their ability to perform complex procedures with greater precision and safety.
Real-time imaging guidance allows surgeons to navigate through anatomical structures and identify critical landmarks with greater clarity and confidence. This facilitates more accurate localization of tumors, blood vessels, nerves, and other structures, reducing the risk of inadvertent injury and improving the overall safety of MIS procedures. Furthermore, imaging technologies enable surgeons to assess tissue perfusion, evaluate the extent of disease, and monitor the progress of surgery in real time, enabling timely adjustments and interventions as needed.
The integration of imaging technologies into MIS platforms enables surgeons to perform minimally invasive procedures with greater efficiency and effectiveness. Advanced imaging modalities, such as three-dimensional (3D) reconstruction and augmented reality (AR) visualization, provide surgeons with enhanced spatial awareness and depth perception, enabling them to navigate complex anatomical structures more intuitively. Additionally, image-guided navigation systems and robotic-assisted surgery platforms offer enhanced dexterity and precision, enabling surgeons to perform intricate maneuvers with greater accuracy and control.
Competitive Landscape Analysis
Key players in Global Minimally Invasive Thoracic Surgery Market include :
- Medtronic plc
- CARDIO MEDICAL GmbH
- Intuitive Surgical
- Richard Wolf GmbH
- Grena Ltd
- Dextera Surgical Inc
- Teleflex Incorporated
- Medela Healthcare
- LivaNova
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Devices
- Market Snapshot, By Region
- Global Minimally Invasive Thoracic Surgery Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological Advancements
- Increasing Prevalence of Thoracic Diseases
- Growing Aging Population
- Demand for Minimally Invasive Procedures
- Restraints
- High Initial Investment Costs
- Technical Complexity and Training Requirements
- Limited Accessibility in Developing Regions
- Risk of Complications and Adverse Events
- Opportunities
- Expansion of Minimally Invasive Techniques
- Advancements in Robotic-Assisted Surgery
- Emerging Markets Penetration
- Integration of Imaging Technologies
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Minimally Invasive Thoracic Surgery Market, By Type, 2021 - 2031 (USD Million)
- Lobectomy
- Wedge Resection
- Pneumonectomy
- Others
- Global Minimally Invasive Thoracic Surgery Market, By Devices, 2021 - 2031 (USD Million)
- Rigid Endoscopes
- Flexible Endoscopes
- Global Minimally Invasive Thoracic Surgery Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Minimally Invasive Thoracic Surgery Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic plc
- CARDIO MEDICAL GmbH
- Intuitive Surgical
- Richard Wolf GmbH
- Grena Ltd
- Dextera Surgical Inc
- Teleflex Incorporated
- Medela Healthcare
- LivaNova
- Company Profiles
- Analyst Views
- Future Outlook of the Market